In the US, Desvenlafaxine (desvenlafaxine systemic) is a member of the drug class serotonin-norepinephrine reuptake inhibitors and is used to treat ADHD, Anxiety, Bipolar Disorder, Depression, Fibromyalgia, Hot Flashes, Major Depressive Disorder, Narcolepsy, Neuralgia, Obesity, Panic Disorder, Post Traumatic Stress Disorder and Postmenopausal Symptoms.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Antidepressant: Selective serotonin and noradrenalin reuptake inhibitor (SSNRI)
- Desvenlafaxinum (Latin)
- Desvenlafaxin (German)
- Dèsvenlafaxine (French)
- Desvenlafaxina (Spanish)
- Desvenlafaxine (OS: BAN)
- O-Desmethylvenlafaxine (IS)
- Desvenlafaxine Succinate (OS: USAN)
- DVS 233 (IS)
- Wy-45233 (IS: Wyeth)
Pfizer, Canada; Pfizer, Ecuador; Wyeth, Chile; Wyeth, Colombia; Wyeth, Guatemala; Wyeth, Honduras; Wyeth, Mexico; Wyeth, Nicaragua; Wyeth, Panama; Wyeth, El Salvador; Wyeth, United States; Wyeth Ayerst, Costa Rica
|BAN||British Approved Name|
|IUPAC||International Union of Pure and Applied Chemistry|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.